World's Best Scientists 2026 revealed!
Journal of Inflammation
H-index 12

Journal of Inflammation

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 205 13 17 6
Microbiology 295 4 4 3

Additional Metrics

Number of Best Scientists*: 62
Documents by Best Scientists*: 55
Top 100 Ranked Scientists*: 1
SCIMAGO H-index:
SCIMAGO SJR:
Impact Factor: N/A

Overview

Top Research Topics at Journal of Inflammation?

Journal of Inflammation focuses largely on the fields of Immunology, Inflammation, Internal medicine, Endocrinology and Pharmacology. The in-depth study on Immunology also explores topics in the intersecting field of Molecular medicine. Issues in Inflammation were discussed, taking into consideration concepts from other disciplines like Receptor, Cancer research, Cell biology and Pathology.

Signal transduction is a key component of Cell biology research discussed in the journal. Most of the Internal medicine studies addressed also intersect with Gastroenterology. While Pharmacology is the focus of Journal of Inflammation, it also provided insights into the studies of In vitro and In vivo.

The studies on Cytokine discussed can also contribute to research in the domains of Chemokine and Molecular biology. Journal of Inflammation is focused mainly on Immune system, particularly Innate immune system. The Tumor necrosis factor alpha study featured in the journal draws connections with the study of Lipopolysaccharide.

  • Immunology (45.45%)
  • Inflammation (34.19%)
  • Internal medicine (27.27%)

What are the most cited papers published in the journal?

  • MESENCHYMAL STEM CELLS AVOID ALLOGENEIC REJECTION (699 citations)
  • Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis (332 citations)
  • Role of IL-33 in inflammation and disease (321 citations)

Research areas of the most cited articles at Journal of Inflammation:

The most cited publications focus largely on the fields of Immunology, Inflammation, Cytokine, Tumor necrosis factor alpha and Internal medicine. The journal publications focus on Immunology but the discussions also offer insight into other areas such as Receptor, Molecular medicine and Cell biology. The journal publications with studies in Inflammation featured incorporate elements of Oxidative stress, Secretion, Pathology, Adipose tissue and Pharmacology.

What topics the last edition of the journal is best known for?

  • Gene
  • Internal medicine
  • Enzyme

The previous edition focused in particular on these issues:

The journal investigates areas of study like Inflammation, Proinflammatory cytokine, Apoptosis, Cancer research and Internal medicine. The research on Inflammation tackled can also make contributions to studies in the areas of Tumor necrosis factor alpha, Lipopolysaccharide, Peripheral blood mononuclear cell, Cell biology and Lung injury. The overlapping concepts between Secretion and Immunology are the key highlights of Peripheral blood mononuclear cell study.

The journal addresses concerns in Immunology which are intertwined with other disciplines, such as Disease and Genotype. The research on Cancer research featured in it combines topics in other fields like Fibrosis, Idiopathic pulmonary fibrosis, Cytokine and MAPK/ERK pathway. Diabetes mellitus, Endocrinology and Palmitic acid are some topics wherein Internal medicine research discussed in the journal have an impact.

The most cited articles from the last journal are:

  • Anti-inflammatory potential of Quercetin in COVID-19 treatment (17 citations)
  • Lactobacillus fermentum CQPC07 attenuates obesity, inflammation and dyslipidemia by modulating the antioxidant capacity and lipid metabolism in high-fat diet induced obese mice (5 citations)
  • Inflammatory M1-like macrophages polarized by NK-4 undergo enhanced phenotypic switching to an anti-inflammatory M2-like phenotype upon co-culture with apoptotic cells (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Inflammation (based on the number of publications) are:

  • Ian M. Adcock (15 papers) published 1 paper at the last edition,
  • Adriano G. Rossi (9 papers) absent at the last edition,
  • Cara M. M. Williams (6 papers) absent at the last edition,
  • Bruce Beutler (5 papers) absent at the last edition,
  • Reza Rahbarghazi (5 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Inflammation (based on the number of publications) are:

  • National Institutes of Health (21 papers) published 1 paper at the last edition,
  • University of Edinburgh (15 papers) absent at the last edition,
  • Pfizer (15 papers) absent at the last edition,
  • Anhui Medical University (8 papers) absent at the last edition,
  • University of Aberdeen (8 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 17.86% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 4.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.39% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.70% of all publications and 69.57% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD

    (2022)
    29 Citations
  • Induction of pyroptotic cell death as a potential tool for cancer treatment

    (2022)
    25 Citations
  • Combination of IL-17A/F and TNF-α uniquely alters the bronchial epithelial cell proteome to enhance proteins that augment neutrophil migration

    (2022)
    13 Citations
  • Offspring sex affects the susceptibility to maternal smoking-induced lung inflammation and the effect of maternal antioxidant supplementation in mice.

    Baoming Wang;Baoming Wang;Yik Lung Chan;Yik Lung Chan;Shengyu Zhou;Sonia Saad

    (2020)
    12 Citations
  • Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis

    (2023)
    9 Citations
  • Bystander effect of SARS-CoV-2 spike protein on human monocytic THP-1 cell activation and initiation of prothrombogenic stimulus representing severe COVID-19

    (2022)
    9 Citations
  • Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance

    (2023)
    8 Citations
  • Enhanced inflammasome activation and reduced sphingosine-1 phosphate S1P signalling in a respiratory mucoobstructive disease model

    Hai B. Tran;Hai B. Tran;Matthew G. Macowan;Matthew G. Macowan;Adrian Abdo;Martin Donnelley;Martin Donnelley

    (2020)
    6 Citations
  • Analysis of AT7519 as a pro-resolution compound in an acetaminophen-induced mouse model of acute inflammation by UPLC-MS/MS

    (2023)
    5 Citations
  • The antigen CD300e drives T cell inflammation in adipose tissue and elicits an antibody response predictive of the insulin sensitivity recovery in obese patients

    (2022)
    5 Citations

Best Scientists Contributing to This Journal